Axsome Therapeutics
Price & Volume
Stats
See more52W Range | $112.90-$260.19 |
Market Cap | $10.7B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $776.5M |
Revenue Growth (YoY) | 45.5% |
Gross Profit (12 Mos) | $724M |
Diluted EPS | -$3.76 |
News
See moreYahoo Finance • 3 days ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Yahoo Finance • 17 days ago
Axsome signals 1 NDA per year through 2030 as AXS-12 targets May 1, 2027 PDUFA
Yahoo Finance • 17 days ago
Here are the major earnings before the open Monday
Yahoo Finance • 21 days ago
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
About
CEO | Dr. Herriot Tabuteau M.D. |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,346 |